» Authors » Elif Yelda Ozgun Niksarlioglu

Elif Yelda Ozgun Niksarlioglu

Explore the profile of Elif Yelda Ozgun Niksarlioglu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 44
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Celebi Sozener Z, Oguzulgen I, Ozalp Ates F, Baccioglu A, Argun Baris S, Ediger D, et al.
J Asthma . 2025 Feb; :1-11. PMID: 39932533
Objective: The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess the differences between obese and non-obese patients with asthma. Methods: This research is a...
2.
Arslan B, Turk M, Hayme S, Aydin O, Gokmen D, Koycu Buhari G, et al.
Clin Transl Allergy . 2025 Jan; 15(1):e70018. PMID: 39865387
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death. Objective:...
3.
Beyaz S, Erdinc M, Hayme S, Aslan A, Aydin O, Gokmen D, et al.
Allergol Immunopathol (Madr) . 2025 Jan; 53(1):12-25. PMID: 39786871
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This...
4.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen I, Soyyigit S, et al.
Respir Med . 2024 Dec; 236:107883. PMID: 39617354
Current guidelines recommend adding long-acting muscarinic antagonists (LAMAs) in patients with uncontrolled asthma, despite the use of moderate to high doses of inhaled steroid-long-acting beta agonists (ICS/LABA). This study aims...
5.
Cakir Edis E, Cilli A, Kizilirmak D, Sakar Coskun A, Guler N, Cicek S, et al.
Balkan Med J . 2024 May; 41(3):206-212. PMID: 38700365
Background: Bronchiectasis is a chronic lung disease characterized by permanent bronchial wall dilatation. Although it has been known as an orphan disease, it has recently gained attention because of registry-based...
6.
Kizilirmak D, Yilmaz Kaya Z, Gokcimen G, Havlucu Y, Ozyurt B, Gundogus B, et al.
Cancer Epidemiol . 2023 Oct; 87:102480. PMID: 37897971
Background: Lung cancer is the leading cause of cancer-related deaths worldwide. Before beginning lung cancer treatment, it is necessary to complete procedures such as suspecting lung cancer, obtaining a pathologic...
7.
Celik G, Aydin O, Gokmen D, Koycu Buhari G, Celebi Sozener Z, Gemicioglu B, et al.
J Asthma . 2023 Apr; 60(11):1973-1986. PMID: 37096963
Introduction: National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry...
8.
Gul S, Uysal M, Cifter A, Ozgun Niksarlioglu E, Bilici D
Turk Thorac J . 2022 Aug; 23(5):331-335. PMID: 35943070
Objective: The coronavirus disease-2019 pandemic has affected the entire health system and patients other than coronavirus-infected patients. Hospital admissions of cancer patients decreased during the closure periods due to the...
9.
Gul S, Akalin Karaca E, Ozgun Niksarlioglu E, Cinarka H, Uysal M
Tuberk Toraks . 2022 Apr; 70(1):8-14. PMID: 35362300
Introduction: Coronavirus disease 2019 (COVID-19) and tuberculosis are serious and mortal diseases worldwide. There are few studies about the association between tuberculosis and COVID-19 pneumonia. We aimed to describe the...
10.
Ozcelik N, Aksel N, Bulbul Y, Erdogan Y, Guldaval F, Gul S, et al.
Tuberk Toraks . 2019 Nov; 67(3):197-204. PMID: 31709951
Introduction: The results of standard chemotherapy in lung cancer are not very satisfactory, so it is important to identify genetic mutations that provide targeted therapies. Recent reports have suggested influences...